Article Information
History
- April 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Christine Dahlke1,2,3,*,
- Jasmin Heidepriem4,
- Robin Kobbe5,
- René Santer5,
- Till Koch1,2,3,
- Anahita Fathi1,2,3,
- My L. Ly1,2,3,
- Stefan Schmiedel1,2,
- Peter H. Seeberger4,
- ID-UKE COVID-19 study group,
- Marylyn M. Addo1,2,3,* and
- Felix F. Loeffler4,6,*
- 1Division of Infectious Diseases, First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 2Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
- 3German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany
- 4Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Muehlenberg 1, 14476 Potsdam, Germany
- 5Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 6Bioprocess Engineering, Department of Biotechnology, Technische Universität Berlin, Berlin, Germany
- ↵*Correspondence:
Marylyn M. Addo (M.M.A.), Division of Infectious Diseases, First Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany, Christine Dahlke (C.D.), Division of Infectious Diseases, First Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany, Felix F. Loeffler (F.F.L.), Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Muehlenberg 1, 14476 Potsdam, Germany felix.loeffler{at}mpikg.mpg.de
Posted April 17, 2020.
Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
